The effect of the volume of procedures at transplantation centers on mortality after liver transplantation.

Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg (2000) 3.83

Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg (2002) 2.71

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64

Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data. BMJ (2002) 2.41

Spine patient outcomes research trial: do outcomes vary across centers for surgery for lumbar disc herniation? Neurosurgery (2012) 2.10

Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut (2007) 1.51

Low-volume deceased donor liver transplantation alongside a strong living donor liver transplantation service. World J Surg (2014) 1.40

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut (2002) 1.29

Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg (2006) 1.28

Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg (2004) 1.24

Measuring surgical quality: what's the role of provider volume? World J Surg (2005) 1.24

Volume of procedures at transplantation centers and mortality after liver transplantation. N Engl J Med (2000) 1.08

Decision for retransplantation of the liver: an experience- and cost-based analysis. Ann Surg (2002) 1.05

Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg (2001) 1.01

Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg (2007) 0.99

Impact of the center on graft failure after liver transplantation. Liver Transpl (2013) 0.98

Transplant center volume and outcomes after liver retransplantation. Am J Transplant (2008) 0.91

Centre volume and resource consumption in liver transplantation. HPB (Oxford) (2012) 0.87

Population-based review of the outcomes following hepatic resection in a Canadian health region. Can J Surg (2009) 0.85

Predictors of implantable pulse generator placement after sacral neuromodulation: who does better? Neuromodulation (2013) 0.84

Effect of centre volume and high donor risk index on liver allograft survival. HPB (Oxford) (2011) 0.80

Variation in outcomes across centers after surgery for lumbar stenosis and degenerative spondylolisthesis in the spine patient outcomes research trial. Spine (Phila Pa 1976) (2013) 0.80

Would increasing centre volumes improve patient outcomes in peritoneal dialysis? A registry-based cohort and Monte Carlo simulation study. BMJ Open (2013) 0.80

Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol (2014) 0.79

A nationwide assessment of outcomes after bile duct reconstruction. HPB (Oxford) (2015) 0.79

Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil. Clinics (Sao Paulo) (2011) 0.77

Temporal trends in liver transplant centre volume in the USA. HPB (Oxford) (2009) 0.75

Volume of procedures at transplantation centers and mortality after liver transplantation. N Engl J Med (2000) 0.75

The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study. PLoS One (2016) 0.75

Volume-outcome relationship in revision hip replacement - Results from a low volume hospital. J Orthop (2013) 0.75

Payer leverage and hospital compliance with a benchmark: a population-based observational study. BMC Health Serv Res (2007) 0.75

Volume of procedures at transplantation centers and mortality after liver transplantation. N Engl J Med (2000) 0.75

Poor outcomes for children on the wait list at low-volume kidney transplant centers in the United States. Pediatr Nephrol (2016) 0.75

Trends in the epidemiology of major burn injury among hospitalized patients: A population-based analysis. J Trauma Acute Care Surg (2017) 0.75

[Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only]. Herz (2009) 0.75

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50

Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol (1973) 4.78

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med (1992) 4.33

"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33

Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16

Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis (1990) 2.91

Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol (1999) 2.79

The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54

Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant (2006) 2.53

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50

Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33

Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int (2006) 2.18

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17

Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology (1992) 2.09

Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09

Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant (2013) 2.02

American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00

Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant (2014) 2.00

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00

Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol (1999) 1.95

Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92

OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation? Am J Transplant (2008) 1.88

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol (1995) 1.82

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82

Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology (1995) 1.81

Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med (1992) 1.80

C3b inactivator of man. 3. Further purification and production of antibody to C3b INA. J Immunol (1972) 1.64

Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med (1991) 1.58

Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57

The role of monocytes in serum sickness nephritis. J Exp Med (1979) 1.55

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther (1997) 1.55

Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51

Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50

Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials (1991) 1.45

The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation (1995) 1.43

Pelvic floor physiology in women with faecal incontinence and urinary symptoms. Br J Surg (1995) 1.41

Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology (1992) 1.41

A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation (1992) 1.40

Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation (1993) 1.38

Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. Surg Gynecol Obstet (1986) 1.35

Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data. Transplantation (2001) 1.33

Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis (1996) 1.31

The effect of transplant center volume on cardiac transplant outcome. A report of the United Network for Organ Sharing Scientific Registry. JAMA (1994) 1.28

Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant (2006) 1.27

Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. JAMA (1998) 1.27

The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26

Liver transplantation for fulminant hepatic failure. Arch Surg (1993) 1.23

Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg (1990) 1.23

Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant (2008) 1.21

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther (1992) 1.19

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology (1996) 1.19

Anatomical landmarks of the inguinal canal in prepubescent children. Aust N Z J Surg (1997) 1.18

Report of a consensus conference on transplant program quality and surveillance. Am J Transplant (2012) 1.18

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology (1996) 1.17

Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol (1993) 1.17

Multiple endocrine adenomatosis type IIb. Diagnosis and treatment. JAMA (1975) 1.17

Long-term complications of living donor liver transplantation. Liver Transpl (2000) 1.16

ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13

Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study. Ann Surg (2000) 1.13

Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology (1992) 1.12

Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics (1991) 1.12

Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation (1989) 1.12

Management of rectal prolapse in children. Dis Colon Rectum (2005) 1.10

Transplanting kidneys without points for HLA-B matching: consequences of the policy change. Am J Transplant (2011) 1.08

Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg (1995) 1.05

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology (1998) 1.05

Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int (1981) 1.04

Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat (2011) 1.04

Foreign body ingestion causing gastric and diaphragmatic perforation in a child. Pediatr Surg Int (2005) 1.04

Laparoscopic excision of a prostatic utricle in a child. Pediatr Surg Int (2003) 1.03

Chain transplantation: initial experience of a large multicenter program. Am J Transplant (2012) 1.02

Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant (2001) 1.02

Erythromycin and cyclosporine. Transplantation (1986) 1.01

Withdrawal of steroids after renal transplantation--clinical predictors of outcome. Transplantation (1992) 1.01

Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med (1992) 1.01

The use of the T tube after orthotopic liver transplantation. Transplantation (1996) 1.01

Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation (1999) 1.00

Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int (1999) 1.00

Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol (1990) 0.99

Liver transplantation for sclerosing cholangitis. Hepatology (1995) 0.98

Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology (1994) 0.98

Transporting live donor kidneys for kidney paired donation: initial national results. Am J Transplant (2011) 0.98

The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group. Nephrol Dial Transplant (2000) 0.98

Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma. Am J Transplant (2007) 0.96

Gender differences in liver donor quality are predictive of graft loss. Am J Transplant (2011) 0.96

Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients. Transplant Proc (2010) 0.95

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis (1991) 0.94

Temporal changes of MR findings in central pontine myelinolysis. AJNR Am J Neuroradiol (1995) 0.93

Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membership. Am J Transplant (2009) 0.93

Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. J Immunol (1999) 0.93

Transplant center regulations--a mixed blessing? An ASTS Council viewpoint. Am J Transplant (2008) 0.93

Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats. Kidney Int (1985) 0.93

Extracellular fluid deficit following operation and its correction with Ringer's lactate. A reassessment. Ann Surg (1985) 0.92

Small bowel motility following major intra-abdominal surgery: the effects of opiates and rectal cisapride. Gastroenterology (1994) 0.91